Sexually transmitted diseases (STDs), or sexually transmitted infections (STIs), are an important global health priority because of their devastating impact on women and infants and their inter-relationships with HIV/AIDS biologically and epidemiologically. The ultimate objective of NIAID-supported research is to develop effective prevention and treatment approaches to control STDs. To develop these strategies, basic research is necessary toward understanding the structure, function, growth, pathogenesis, and evolution of STD bacterial, viral, parasitic, protozoan, and fungal agents. Another important aspect of basic research is to examine the impact of STDs in various populations.
NIAID work in genomic sequencing further accelerates STD biological research and discovery. NIAID has collected genomic data on STD pathogens and made it available to qualified researchers through public databases. Recent advances include the genomic sequencing of pathogens responsible for trichomoniasis, chlamydia, gonorrhea, and human genital ulcer disease (chancroid). The sequencing of genomes allows researchers to read and decipher genetic data that may aid in the development of novel diagnostics, topical medications, and vaccines.
NIAID is always accepting researcher-initiated applications. Connect with NIAID program officers about potential funding for STD/STI research.
- Dr. Thomas Hiltke, STIs Section Chief, STI Vaccines and Therapeutics Program Officer
- Kimberly Murphy, Product Development Project Manager for STIs
- Dr. Leah Vincent, STIs Basic Research Program Officer
- Peter Wolff, Clinical Trials Specialist
Resources for Researchers
You may request services if you are an investigator in academia, a not-for-profit organization, industry, or government in the United States or worldwide. You need not be a grantee of NIAID or another National Institutes of Health Institute or Center. Look to each resource for further eligibility information.
Connect With Other Researchers
Researchers at NIAID
Much of the STD research ongoing at NIAID takes place in these laboratories:
Laboratory of Immunoregulation
- Thomas C. Quinn, M.D., M.Sc., International HIV/STD Section
- Steven J. Reynolds, M.D., M.P.H., International HIV/STD Section
Laboratory of Infectious Diseases
- Jeffrey Cohen, M.D., Medical Virology Section
Laboratory of Viral Diseases
Laboratory of Bacteriology
- David (Ted) Hackstadt, Ph.D., Host-Parasite Interactions Section
Laboratory of Clinical Immunology and Microbiology
- Harlan D. Caldwell, Ph.D., Chlamydial Diseases Section
Current Challenges in Evaluating Antimicrobials for Urogenital Gonorrhea
Experts Collaborate to Design Thorough and Effective Future Trials
February 5-6, 2019